Pain Management

The combination of COVID-19 with opioid-induced respiratory depression, especially in an elderly patient, could be deadly.

According to the study results, women interested in medical cannabis reported marginally lower levels of support from their primary care provider and significantly less support from specialist physicians.

Webinar participants discuss best practices for pharmacists with patients contending with both issues.

A CDC report reveals that approximately 9% of teens between the ages of 15 and 19 received an opioid prescription in 2018.

In a recent study analyzing US commercial dental visits between 2011 and 2015, 29.3% of dental visits included opioid prescriptions that exceeded the recommended amount of less than 80 morphine milligram equivalents.

Cannabis use is becoming much more prevalent in the United States, as several more states have recently legalized it for recreational or medicinal use.

Statin use in certain patients may lead to increased muscle pain so severe it can affect adherence.

Approximately 1 in 3 high school seniors (31.8%) who reported misusing prescription opioids as high school seniors between 1997 and 2000 went on to use heroin by age 35.

This month's featured products include magnesium chews, pre and probiotic fiber, and more.

When 3 citizens of a Southern state file suit against government officials to have a state statute classifying marijuana as an illegal substance declared unconstitutional, should the courts make such a declaration and issue an injunction prohibiting enforcement of the laws?

This month's case studies feature lower back pain, hand osteoarthritis, and more.

The new project follows a collaboration with Walmart announced in August, offering a free comprehensive online training program on opioid stewardship.

Given the evidence of emotional trauma, hopelessness, and social isolation as risk factors for addiction, compassion and support are critical.

The study found that of 568 patients surveyed, 15% had used cannabis within the past 3 years, with half of the users reporting using it regularly and mostly for medical purposes.

Although earlier research has shown slight reductions in opioid abuse rates, this analysis is the first to show statistically significant year-to-year declines.

This webcast discusses a number of topics pertaining to the substance use epidemic and updates in the use of naloxone especially during the COVID-19 pandemic.

For any patient in hospice, the advent of myriad therapeutic interventions can help achieve comfort and pain relief.

One afternoon, an emergency department pharmacist receives a medication order to verify. It’s for 10 mg of morphine through IV. The pharmacist notices the dose is unusually high and realizes it could potentially be lethal.

The types of SUDs investigated were tobacco, alcohol, opioid, cannabis, and cocaine.

Eliminating Kickbacks in Recovery Act of 2018 Is an attempt to eliminate ‘patient brokering’.

Study suggests up to 75% of online pharmacies are illegitimate and pose serious health concerns.

Investigators found that approximately 36% of the patients studied received a dosage strength of 250 mg of morphine over a 5-day period, above the CDC’s threshold for risky opioid prescribing.

In the United States, it is estimated that 34 million school hours and $45 billion are lost each year to unplanned dental care.

New online training program is being deployed in response to data indicating a surge in opioid-related overdoses during the COVID-19 pandemic.

Olicerdine is indicated for patients with severe pain who require an intravenous opioid when alternative treatments prove inadequate.

The Department of Health and Human Services awarded $101 million, mostly to rural communities, to fight the opioid epidemic.

With a growing number of products containing cannabidiol and kratom available in the marketplace, many pharmacists and pharmacy students are increasingly being asked to discuss the use of these products.

Perhaps no other health care worker has been exposed to the opioid epidemic more frequently than pharmacy technicians and pharmacists.

In a recent statement, the FDA provided some guidelines for health care professionals when prescribing or renewing an opioid analgesic or medicine to treat opioid use disorder.

The FDA released a recent statement explaining that it is now recommending all pharmacists discuss naloxone with patients when prescribing opioid pain relievers or medicines to treat opioid use disorder (OUD).